Does TMS Work? An Honest Guide to Response and Remission in Georgia

Does TMS work for depression?

Transcranial magnetic stimulation, usually called TMS, can help some people with major depressive disorder, particularly when medicines, talking therapies or both have not brought enough improvement. It is not a guaranteed treatment, and the experience varies considerably from one person to another.

TMS uses magnetic pulses applied to particular areas of the scalp. These pulses are intended to influence brain networks involved in mood and emotional regulation. Treatment is normally provided while you are awake, in an outpatient setting, and does not require anaesthesia.

TMS was cleared by the US Food and Drug Administration for major depressive disorder in 2008. It was later cleared for depression with comorbid anxiety in 2021. FDA clearance does not mean that every person will respond, but it reflects evidence that the treatment can be effective and acceptably safe when used for its cleared purpose.

When people ask whether TMS “works”, it helps to ask what outcome they mean. In clinical research and in real-world care, two terms are especially important: response and remission.

What does “response” mean?

A response means that depression symptoms have improved by a meaningful amount compared with the person’s starting point.

In research, response is often defined using a standard depression questionnaire. A person may be considered a responder when their score has reduced by around half. That does not necessarily mean every symptom has gone. Someone may still have low energy, sleep disruption, anxious thoughts or difficulty enjoying things, but may be functioning better and feeling less overwhelmed than before treatment.

Response can matter a great deal in day-to-day life. It may mean:

• getting out of bed more reliably;
• returning to work, study or caring responsibilities;
• feeling less hopeless or tearful;
• having more concentration and motivation;
• finding therapy, relationships or healthy routines easier to engage with.

A response is therefore a significant result, even when it is not full recovery.

What does “remission” mean?

Remission generally means that a person’s depression symptoms have reduced to a very low level, or are no longer causing substantial day-to-day impairment.

This is a stricter outcome than response. Someone in remission may still have occasional bad days, stress, grief or understandable emotional reactions. Remission does not mean that a person will never feel depressed again. Instead, it means they are no longer meeting the usual threshold for an active depressive episode, based on symptoms and functioning.

For many people, remission is the goal. For others, an important reduction in symptoms may be the realistic first aim, especially if depression has been severe, long-lasting or accompanied by other health concerns.

Clinicians may use rating scales alongside regular conversations about sleep, mood, functioning, side effects and safety. The numbers on a questionnaire are useful, but they are not the whole story. A meaningful outcome should reflect how a person is actually managing their life.

What published TMS trials generally report

Published studies of TMS for major depressive disorder commonly report that a substantial proportion of participants improve, and that some reach remission. Results vary between studies because they include different groups of people, use different treatment protocols and measure outcomes in different ways.

Trials often focus on people whose depression has not improved enough with antidepressant medication. This is important when interpreting results. A study involving people with treatment-resistant depression may have different outcomes from one involving people earlier in their treatment journey.

Research findings are usually reported in several ways:

• Response rates: the proportion of participants whose symptoms reduce substantially.
• Remission rates: the proportion whose symptoms fall to a low level.
• Average symptom change: how much questionnaire scores reduce across the group as a whole.
• Durability of benefit: whether improvement remains after the acute treatment course.
• Tolerability: side effects, treatment completion and reasons people stop.

No single published figure can reliably predict what will happen for an individual in Georgia. A result from a controlled trial is also not identical to the result someone may experience in ordinary clinical care. Trials have specific eligibility rules and closely structured treatment plans. In practice, people may have additional diagnoses, changing life circumstances, medication changes or difficulties attending every appointment.

The fairest summary is that TMS is an evidence-based option that helps some people with depression, including some who have not had enough benefit from other treatments. It does not work equally well for everyone, and remission cannot be promised.

Why individual TMS results vary

Depression is not one uniform condition. Two people may both receive a diagnosis of major depressive disorder while having very different symptom patterns, histories and contributing factors. That is one reason results vary.

Factors that may influence an individual’s outcome include:

• how long depression has been present;
• the severity of symptoms at the start of treatment;
• previous response to medicines, therapy or other treatments;
• whether anxiety, trauma symptoms, substance use, chronic pain or another mental health condition is also present;
• physical health conditions and current medicines;
• whether the person can attend consistently;
• the type of TMS protocol selected by the treating clinician;
• support at home, work pressures and major life events during treatment.

These factors do not create a simple pass-or-fail prediction. For example, having longstanding depression does not mean TMS cannot help. Likewise, a person with fewer previous treatments cannot assume remission is certain. An assessment should consider the full clinical picture rather than relying on a single feature.

Timing matters: improvement may be gradual

A standard TMS course is often about 36 weekday sessions, delivered across roughly six to nine weeks. Some people notice changes early, such as better sleep, less mental fog or a little more energy. Others notice improvement later in the course.

Mood change may not follow a straight line. A person can have a better week followed by a more difficult few days, particularly if other stresses are ongoing. Regular review helps the treating team understand whether symptoms are changing and whether the plan remains appropriate.

It is also worth distinguishing between feeling more activated and feeling better. Energy can sometimes improve before mood does. A person who has concerns about worsening agitation, unusual mood elevation, suicidal thoughts or any major change in their mental state should tell their clinician promptly.

What TMS can and cannot tell you before treatment

A clinic assessment can help determine whether TMS may be suitable and whether there are reasons to use caution. It should cover depression symptoms, treatment history, medicines, mental and physical health, and any factors that could affect safety.

However, no assessment can accurately guarantee response or remission. Be wary of any service that suggests otherwise. A reasonable discussion should include possible benefits, limitations, alternatives, side effects, practical attendance requirements and what follow-up may look like.

Common side effects include scalp discomfort during treatment and headache afterwards. These are usually temporary. Seizure is rare, but it is a recognised risk and should be discussed as part of informed consent.

TMS is often considered alongside, rather than automatically instead of, other forms of care. Depending on the individual, this may include medication management, psychological therapy, sleep support, substance-use support or help with social and practical pressures.

Considering access and insurance in Georgia

Georgia has a wide range of locations where people may seek a TMS assessment. TMS Therapy Georgia currently lists 255 published clinics in its directory, including listings in Atlanta, Alpharetta, Johns Creek, Grovetown, Snellville, Cumming, Columbus, Evans, Pooler, Sandy Springs, Norcross and Smyrna.

Availability, referral requirements and insurance processes can differ between providers. Plans commonly seen in Georgia include Anthem Blue Cross Blue Shield Georgia, Aetna, Cigna, UnitedHealthcare, Humana, Peach State Health Plan / Georgia Medicaid, Medicare including Medicare Advantage plans, and TRICARE East.

Coverage is not automatic simply because a plan is listed by a clinic. Insurers may have their own criteria, which can involve diagnosis, past treatment history, clinical documentation and prior authorisation. Contacting both the clinic and insurer can help clarify what information is needed before beginning treatment.

Getting help in Georgia

Use the TMS Therapy Georgia clinic listings to compare published providers, read the insurance guide for practical coverage questions, and visit the contact page if you need help using the directory.

This article is educational information, not medical advice.